Статті в журналах з теми "CDKIs"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "CDKIs".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Campbell, Grace Jean, Emma Langdale Hands, and Mathew Van de Pette. "The Role of CDKs and CDKIs in Murine Development." International Journal of Molecular Sciences 21, no. 15 (July 28, 2020): 5343. http://dx.doi.org/10.3390/ijms21155343.
Повний текст джерелаGiannone, Gaia, Valentina Tuninetti, Eleonora Ghisoni, Sofia Genta, Giulia Scotto, Gloria Mittica, and Giorgio Valabrega. "Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer." International Journal of Molecular Sciences 20, no. 9 (May 12, 2019): 2353. http://dx.doi.org/10.3390/ijms20092353.
Повний текст джерелаPhuong, Lisa, Janki Patel, Nadia Baka, Jessica Goldman, Michael Lyudmer, Stephanie Shamir, Junwen Deng, Alvaro Alvarez Soto, and Jesus Del Santo Anampa Mesias. "Effect of cyclin-dependent kinase 4 and 6 inhibitors (CDKIs) on body composition (BC) in patients (pts) with hormone receptor-positive, HER2-negative (HR+/HER2-) metastatic breast cancer (MBC)." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e13033-e13033. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e13033.
Повний текст джерелаChao, Sheng-Hao, John R. Walker, Sumit K. Chanda, Nathanael S. Gray, and Jeremy S. Caldwell. "Identification of Homeodomain Proteins, PBX1 and PREP1, Involved in the Transcription of Murine Leukemia Virus." Molecular and Cellular Biology 23, no. 3 (February 1, 2003): 831–41. http://dx.doi.org/10.1128/mcb.23.3.831-841.2003.
Повний текст джерелаDao, Mo A., and Catherine M. Verfaillie. "STI571 Suppresses Proliferation by Restoring Nuclear Cyclin Dependent Kinase Inhibitors (CDKIs) while STI571+TRAIL Promotes Cell Death by Decreasing Cytoplasmic CDKIs." Blood 104, no. 11 (November 16, 2004): 1992. http://dx.doi.org/10.1182/blood.v104.11.1992.1992.
Повний текст джерелаAbdelmalak, Mary, Rajanbir Singh, Mohammed Anwer, Pavel Ivanchenko, Amritdeep Randhawa, Myra Ahmed, Anthony W. Ashton, Yanming Du, Xuanmao Jiao, and Richard Pestell. "The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update on Clinical Trials and Therapy Resistance." Cancers 14, no. 21 (November 1, 2022): 5388. http://dx.doi.org/10.3390/cancers14215388.
Повний текст джерелаGervaso, Lorenzo, Alberto J. Montero, Xuefei Jia, and Alok A. Khorana. "Venous thromboembolism in breast cancer patients receiving cyclin-dependent kinase inhibitors." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e18184-e18184. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e18184.
Повний текст джерелаZeki, K., I. Morimoto, T. Arao, S. Eto, and U. Yamashita. "Interleukin-1alpha regulates G1 cell cycle progression and arrest in thyroid carcinoma cell lines NIM1 and NPA." Journal of Endocrinology 160, no. 1 (January 1, 1999): 67–73. http://dx.doi.org/10.1677/joe.0.1600067.
Повний текст джерелаBuckley, S., B. Driscoll, K. D. Anderson, and D. Warburton. "Cell cycle in alveolar epithelial type II cells: integration of Matrigel and KGF." American Journal of Physiology-Lung Cellular and Molecular Physiology 273, no. 3 (September 1, 1997): L572—L580. http://dx.doi.org/10.1152/ajplung.1997.273.3.l572.
Повний текст джерелаBencivenga, Debora, Emanuela Stampone, Angela Vastante, Myassar Barahmeh, Fulvio Della Ragione, and Adriana Borriello. "An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs." Cells 11, no. 8 (April 14, 2022): 1346. http://dx.doi.org/10.3390/cells11081346.
Повний текст джерелаMason, Jeremy, Yutao Gong, Laleh Amiri-Kordestani, Suparna Wedam, Jennifer J. Gao, Tatiana M. Prowell, Harpreet Singh, et al. "Model Development of CDK4/6 Predicted Efficacy in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer." JCO Clinical Cancer Informatics, no. 5 (June 2021): 758–67. http://dx.doi.org/10.1200/cci.21.00025.
Повний текст джерелаMatushansky, Igor, Farshid Radparvar, and Arthur I. Skoultchi. "Manipulating the onset of cell cycle withdrawal in differentiated erythroid cells with cyclin-dependent kinases and inhibitors." Blood 96, no. 8 (October 15, 2000): 2755–64. http://dx.doi.org/10.1182/blood.v96.8.2755.
Повний текст джерелаMatushansky, Igor, Farshid Radparvar, and Arthur I. Skoultchi. "Manipulating the onset of cell cycle withdrawal in differentiated erythroid cells with cyclin-dependent kinases and inhibitors." Blood 96, no. 8 (October 15, 2000): 2755–64. http://dx.doi.org/10.1182/blood.v96.8.2755.h8002755_2755_2764.
Повний текст джерелаSchwartz, Gary K., and Manish A. Shah. "Targeting the Cell Cycle: A New Approach to Cancer Therapy." Journal of Clinical Oncology 23, no. 36 (December 20, 2005): 9408–21. http://dx.doi.org/10.1200/jco.2005.01.5594.
Повний текст джерелаDeSouza, Karen, Daniel Yeo, Maria Diossy, Sumbal Umar, Emma Gore, Sachin Trivedi, Anjana Anand, Srinivasan Madhusudan, and Sarah Khan. "Real-world outcomes from the systemic use of CDK 4/6 inhibitors (CDKIs) in the management of ER positive (+) HER2 negative (-) metastatic breast cancer (mBC)." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e13031-e13031. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e13031.
Повний текст джерелаRichter, Anna, Nina Schoenwaelder, Sina Sender, Christian Junghanss, and Claudia Maletzki. "Cyclin-Dependent Kinase Inhibitors in Hematological Malignancies—Current Understanding, (Pre-)Clinical Application and Promising Approaches." Cancers 13, no. 10 (May 20, 2021): 2497. http://dx.doi.org/10.3390/cancers13102497.
Повний текст джерелаGao, Jennifer J., Joyce Cheng, Tatiana Michelle Prowell, Erik Bloomquist, Shenghui Tang, Suparna B. Wedam, Melanie E. Royce, et al. "Overall survival in patients with breast cancer treated with a CDK 4/6 inhibitor plus fulvestrant: A U.S. Food and Drug Administration pooled analysis." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 1055. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.1055.
Повний текст джерелаCroucher, David R., Danny Rickwood, Carole M. Tactacan, Elizabeth A. Musgrove, and Roger J. Daly. "Cortactin Modulates RhoA Activation and Expression of Cip/Kip Cyclin-Dependent Kinase Inhibitors To Promote Cell Cycle Progression in 11q13-Amplified Head and Neck Squamous Cell Carcinoma Cells." Molecular and Cellular Biology 30, no. 21 (August 30, 2010): 5057–70. http://dx.doi.org/10.1128/mcb.00249-10.
Повний текст джерелаKhosravi, Mohammad Reza, Mohammad Hossein Mohammadi, Parinaz Khadem, Sahar Lashkari, Hamideh Aghaeenezhad, Ahmad Gharehbaghian, Zaher Khazaei, and Mehdi Allahbakhshian Farsani. "Evaluation of P21Cip1 and P27Kip1 expression in de novo acute lymphoblastic leukemia patients." Biomedical Research and Therapy 5, no. 7 (July 28, 2018): 2518–27. http://dx.doi.org/10.15419/bmrat.v5i7.461.
Повний текст джерелаRoncato, Rossana, Jacopo Angelini, Arianna Pani, Erika Cecchin, Andrea Sartore-Bianchi, Salvatore Siena, Elena De Mattia, Francesco Scaglione, and Giuseppe Toffoli. "CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions." International Journal of Molecular Sciences 21, no. 17 (September 1, 2020): 6350. http://dx.doi.org/10.3390/ijms21176350.
Повний текст джерелаAdona, Paulo Roberto, and Cláudia Lima Verde Leal. "Meiotic inhibition with different cyclin-dependent kinase inhibitors in bovine oocytes and its effects on maturation and embryo development." Zygote 12, no. 3 (August 2004): 197–204. http://dx.doi.org/10.1017/s0967199404002771.
Повний текст джерелаRiess, Christin, Katharina del Moral, Adina Fiebig, Philipp Kaps, Charlotte Linke, Burkhard Hinz, Anne Rupprecht, et al. "HGG-13. Combined CDK inhibition and arginine-deprivation as targeted therapy for arginine-auxotrophic glioblastoma multiforme cells." Neuro-Oncology 24, Supplement_1 (June 1, 2022): i62—i63. http://dx.doi.org/10.1093/neuonc/noac079.228.
Повний текст джерелаMou, Jiajia, Danghui Chen, and Yanru Deng. "Inhibitors of Cyclin-Dependent Kinase 1/2 for Anticancer Treatment." Medicinal Chemistry 16, no. 3 (April 17, 2020): 307–25. http://dx.doi.org/10.2174/1573406415666190626113900.
Повний текст джерелаJerez, Jose Manuel, Nuria Ribelles, Pablo Rodriguez-Brazzarola, Tamara Diaz Redondo, Begoña Jimenez Rodriguez, Alfonso Sanchez-Muñoz, Antonia Marquez, et al. "Prediction of early progression (EP) to CDKIs first line treatment in ER+/HER2- metastatic breast cancer (MBC) using machine learning." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e13040-e13040. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13040.
Повний текст джерелаHan, Xu, Yijin Kuang, Huiyong Chen, Ting Liu, Ji Zhang, and Jing Liu. "p19INK4d: More than Just a Cyclin-Dependent Kinase Inhibitor." Current Drug Targets 21, no. 1 (December 20, 2019): 96–102. http://dx.doi.org/10.2174/1389450120666190809161901.
Повний текст джерелаBryant, Patrick, Qingxia Zheng, and Kevin Pumiglia. "Focal Adhesion Kinase Controls Cellular Levels of p27/Kip1 and p21/Cip1 through Skp2-Dependent and -Independent Mechanisms." Molecular and Cellular Biology 26, no. 11 (June 1, 2006): 4201–13. http://dx.doi.org/10.1128/mcb.01612-05.
Повний текст джерелаCheng, Qiong, Zhikun Ma, Yujie Shi, Amanda B. Parris, Lingfei Kong, and Xiaohe Yang. "FGFR1 Overexpression Induces Cancer Cell Stemness and Enhanced Akt/Erk-ER Signaling to Promote Palbociclib Resistance in Luminal A Breast Cancer Cells." Cells 10, no. 11 (November 4, 2021): 3008. http://dx.doi.org/10.3390/cells10113008.
Повний текст джерелаBonelli, Patrizia, Franca Maria Tuccillo, Antonella Borrelli, Antonietta Schiattarella, and Franco Maria Buonaguro. "CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity." BioMed Research International 2014 (2014): 1–15. http://dx.doi.org/10.1155/2014/361020.
Повний текст джерелаWong, Gail A., Vincent Tang, Faten El-Sabeawy, and Robert H. Weiss. "BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21Cip1/Waf1." American Journal of Physiology-Endocrinology and Metabolism 284, no. 5 (May 1, 2003): E972—E979. http://dx.doi.org/10.1152/ajpendo.00385.2002.
Повний текст джерелаLiu, Wingsze, Coral Olazagasti, Chung-Shien Lee, Taylor Decina, Karalyn Pappas, and Kit Cheng. "A single institution retrospective study of the effect of starting doses in patients with ER-positive metastatic breast cancer on CDK 4/6 inhibitors." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e13056-e13056. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13056.
Повний текст джерелаPerecin, F., S. C. Méo, C. L. V. Leal, and J. M. Garcia. "Oocyte activation and preimplantation development of bovine embryos obtained by specific inhibition of cyclin-dependent kinases." Arquivo Brasileiro de Medicina Veterinária e Zootecnia 59, no. 2 (April 2007): 280–87. http://dx.doi.org/10.1590/s0102-09352007000200002.
Повний текст джерелаTakeuchi, S., HP Koeffler, DR Hinton, I. Miyoshi, S. Melmed, and I. Shimon. "Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors." Journal of Endocrinology 157, no. 2 (May 1, 1998): 337–41. http://dx.doi.org/10.1677/joe.0.1570337.
Повний текст джерелаTakeuchi, S., CR Bartram, T. Seriu, CW Miller, A. Tobler, JW Janssen, A. Reiter, WD Ludwig, M. Zimmermann, and J. Schwaller. "Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood." Blood 86, no. 2 (July 15, 1995): 755–60. http://dx.doi.org/10.1182/blood.v86.2.755.bloodjournal862755.
Повний текст джерелаHoward, David, David James, Kate Murphy, Jezabel Garcia-Parra, Belen Pan-Castillo, Stuart Rex, Annemarie Moul, et al. "Dinaciclib, a Bimodal Agent Effective against Endometrial Cancer." Cancers 13, no. 5 (March 6, 2021): 1135. http://dx.doi.org/10.3390/cancers13051135.
Повний текст джерелаRoman-Gomez, Jose, Juan Antonio Castillejo, Antonio Jimenez, Maria Gracia Gonzalez, Fernanda Moreno, Maria del Carmen Rodriguez, Manuel Barrios, Juan Maldonado, and Antonio Torres. "5′ CpG island hypermethylation is associated with transcriptional silencing of the p21CIP1/WAF1/SDI1 gene and confers poor prognosis in acute lymphoblastic leukemia." Blood 99, no. 7 (April 1, 2002): 2291–96. http://dx.doi.org/10.1182/blood.v99.7.2291.
Повний текст джерелаSemiglazov, V. F., M. A. Dzhelialova, S. S. Yerechshenko, E. T. Munaeva, R. S. Pesotsky, A. I. Tseluyko, A. S. Emelyanov, R. V. Donskikh, and P. V. Krivorotko. "Post-neoadjuvant treatment of breast cancer." Meditsinskiy sovet = Medical Council, no. 9 (July 30, 2020): 232–41. http://dx.doi.org/10.21518/2079-701x-2020-9-232-241.
Повний текст джерелаMoreno-Lorenzana, Dafne, Sócrates Avilés-Vazquez, Miguel Angel Sandoval Esquivel, Antonio Alvarado-Moreno, Vianney Ortiz-Navarrete, Héctor Torres-Martínez, Manuel Ayala-Sánchez, Héctor Mayani, and Antonieta Chavez-Gonzalez. "CDKIs p18INK4cand p57Kip2are involved in quiescence of CML leukemic stem cells after treatment with TKI." Cell Cycle 15, no. 9 (March 17, 2016): 1276–87. http://dx.doi.org/10.1080/15384101.2016.1160976.
Повний текст джерелаGuida, L., M. Annunziata, I. Passaro, C. Buonaiuto, R. Rullo, S. Tetè, F. Della Ragione, and A. Oliva. "Acetylsalicylic Acid Inhibits Proliferation of Human Bone Marrow Stromal Cells and Matrix Mineralization." International Journal of Immunopathology and Pharmacology 21, no. 4 (October 2008): 921–28. http://dx.doi.org/10.1177/039463200802100416.
Повний текст джерелаChang, Mei-Yin, Den-En Shieh, Chung-Chi Chen, Ching-Sheng Yeh, and Huei-Ping Dong. "Linalool Induces Cell Cycle Arrest and Apoptosis in Leukemia Cells and Cervical Cancer Cells through CDKIs." International Journal of Molecular Sciences 16, no. 12 (November 26, 2015): 28169–79. http://dx.doi.org/10.3390/ijms161226089.
Повний текст джерелаCampbell, M. J., E. Elstner, S. Holden, M. Uskokovic, and H. P. Koeffler. "Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin." Journal of Molecular Endocrinology 19, no. 1 (August 1997): 15–27. http://dx.doi.org/10.1677/jme.0.0190015.
Повний текст джерелаAmani, Jafar, Nassim Gorjizadeh, Simin Younesi, Mojtaba Najafi, Arash M. Ashrafi, Saeed Irian, Negar Gorjizadeh, and Khalil Azizian. "Cyclin-dependent kinase inhibitors (CDKIs) and the DNA damage response: The link between signaling pathways and cancer." DNA Repair 102 (June 2021): 103103. http://dx.doi.org/10.1016/j.dnarep.2021.103103.
Повний текст джерелаChen, Jun, Frank Hong, and Perry D. Nisen. "Gene therapy for human brain tumors by ectopic overexpression of cell cycle cyclin-dependent kinase inhibitors (CDKIs) • 646." Pediatric Research 41 (April 1997): 110. http://dx.doi.org/10.1203/00006450-199704001-00666.
Повний текст джерелаRiera, María F., Mariana Regueira, María N. Galardo, Eliana H. Pellizzari, Silvina B. Meroni, and Selva B. Cigorraga. "Signal transduction pathways in FSH regulation of rat Sertoli cell proliferation." American Journal of Physiology-Endocrinology and Metabolism 302, no. 8 (April 15, 2012): E914—E923. http://dx.doi.org/10.1152/ajpendo.00477.2011.
Повний текст джерелаFreidkin, Ilya, Michal Herman, Ana Tobar, Avry Chagnac, Yaacov Ori, Asher Korzets, and Uzi Gafter. "Effects of histone deacetylase inhibitors on rat mesangial cells." American Journal of Physiology-Renal Physiology 298, no. 2 (February 2010): F426—F434. http://dx.doi.org/10.1152/ajprenal.00107.2009.
Повний текст джерелаYang, Zhongfa, Karen Drumea, James Cormier, Junling Wang, Xuejun Zhu, and Alan G. Rosmarin. "Gabp Transcription Factor Is Required for Self-Renew and Proliferation of Hematopoietic Stem and Progenitor Cells." Blood 118, no. 21 (November 18, 2011): 1284. http://dx.doi.org/10.1182/blood.v118.21.1284.1284.
Повний текст джерелаYao, Kevin C., Tadashi Komata, Yasuko Kondo, Takao Kanzawa, Seiji Kondo, and Isabelle M. Germano. "Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of cyclin-dependent kinase inhibitors, and autophagy." Journal of Neurosurgery 98, no. 2 (February 2003): 378–84. http://dx.doi.org/10.3171/jns.2003.98.2.0378.
Повний текст джерелаVelázquez, Carolina, Esin Orhan, Imene Tabet, Lise Fenou, Laura Boudarel, William Jacot, Claude Sardet, and Charles Theillet. "Exploiting DNA Repair Defect in Triple Negative Breast Cancer Using CDK Inhibition Strategy." Medical Sciences Forum 3, no. 1 (January 29, 2021): 13. http://dx.doi.org/10.3390/iecc2021-09212.
Повний текст джерелаFang, Jing, Lyndsey Bolanos, Juana Serrano-Lopez, Susanne Christie, Jose A. Cancelas, and Daniel T. Starczynowski. "TRAF6 Is Essential for Maintaining Hematopoietic Stem Cell Homeostasis." Blood 128, no. 22 (December 2, 2016): 568. http://dx.doi.org/10.1182/blood.v128.22.568.568.
Повний текст джерелаTrivellin, Giampaolo, Ricardo R. Correa, Maria Batsis, Fabio R. Faucz, Prashant Chittiboina, Ivana Bjelobaba, Darwin O. Larco, et al. "Screening for GPR101 defects in pediatric pituitary corticotropinomas." Endocrine-Related Cancer 23, no. 5 (May 2016): 357–65. http://dx.doi.org/10.1530/erc-16-0091.
Повний текст джерелаBeksac, Meral, Ender Soydan, Selami Kocak Toprak, Merih Kizil, Gulsah Kaygusuz, and Isinsu Kuzu. "Marrow Plasma Cell Immunohistochemical Expression Profiles of Cyclins (A, D1, D2, D3), Cyclin Dependent Kinase Inhibitors (p16, p21) and Ki67: Predictors of Survival in Patients with Multiple Myeloma." Blood 106, no. 11 (November 16, 2005): 5117. http://dx.doi.org/10.1182/blood.v106.11.5117.5117.
Повний текст джерела